No other insider has filed at Christopher McCarthy's companies, so these are insiders reporting open-market trades at other companies in the same sector.
Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Christopher McCarthy is a corporate insider, tracked as CFO & COO of INTERPACE BIOSCIENCES, INC. (IDXG). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher McCarthy submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Christopher McCarthy is CFO & COO of INTERPACE BIOSCIENCES, INC. (IDXG). 2 SEC Form 4 filings on record going back to 2025, most recently on 20 August 2026.
Recent transactions
7
The latest 7 SEC Form 4 transactions reported by Christopher McCarthy.
InsiderAlpha's records for Christopher McCarthy go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
